The meta-analysis findings revealed a statistically significant decrease in SOD levels in both erythrocyte samples (P  < 0.001) and tissue samples (P  < 0.05) among individuals with oral cancer (OSCC) compared to the normal control group. This evidence concerns the gene SOD1 and lip and oral cavity carcinoma.